Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation : Clinical Chemical Laboratory Medicine Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue
Loading journal volume and issue information...

Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation

Christoph L. Klein1 / János Márki-Zay2 / Philippe Corbisier3 / David Gancberg4 / Susan Cooper5 / Donato Gemmati6 / Walter-Michael Halbmayer7 / Steve Kitchen8 / Béla Melegh9 / Michael Neumaier10 / Johannes Oldenburg11 / Elisabeth Oppliger Leibundgut12 / Pieter H. Reitsma13 / Sandra Rieger14 / Heinz G. Schimmel15 / Michael Spannagl16 / Attilia Tordai17 / Alberto Tosetto18 / Sophie Visvikis19 / Renata Zadro20 / Christine Mannhalter21

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.

17.

18.

19.

20.

21.

Corresponding author: Christoph L. Klein, European Commission, Joint Research Centre, Institute for Reference Materials and Measurements, Retieseweg 111, 2440 Geel, Belgium Phone: +32-14-571634, Fax: +32-14-571548,

Citation Information: Clinical Chemical Laboratory Medicine. Volume 43, Issue 8, Pages 862–868, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2005.145, August 2005

Publication History

Received:
March 7, 2005
Accepted:
June 17, 2005

Abstract

The Scientific Committee of Molecular Biology Techniques (C-MBT) in Clinical Chemistry of the IFCC has initiated a joint project in co-operation with the European Commission, Joint Research Centre, Institute of Reference Materials and Measurements to develop and produce plasmid-type reference materials (RMs) for the analysis of the human prothrombin gene G20210A mutation. Although DNA tests have a high impact on clinical decision-making and the number of tests performed in diagnostic laboratories is high, issues of quality and quality assurance exist, and currently only a few RMs for clinical genetic testing are available. A gene fragment chosen was produced that spans all primer annealing sites published to date. Both the wild-type and mutant alleles of this gene fragment were cloned into a pUC18 plasmid and two plasmid RMs were produced. In addition, a mixture of both plasmids was produced to mimic the heterozygous genotype. The present study describes the performance of these reference materials in a commutability study, in which they were tested by nine different methods in 13 expert laboratories. This series of plasmid RMs are, to the best of our knowledge, the first plasmid-type clinical genetic RMs introduced worldwide.

Keywords: metrological traceability; molecular diagnostic testing; mutation; polymerase chain reaction; prothrombin; recombinant DNA; reference standards

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Martin Beranek, Monika Drastikova, Petr Dulicek, and Vladimir Palicka
Biomedical Papers, 2014
[2]
David Gancberg, Philippe Corbisier, Nele Meeus, Janos Marki-Zay, Christine Mannhalter, and Heinz Schimmel
Clinical Chemistry and Laboratory Medicine, 2008, Volume 46, Number 4

Comments (0)

Please log in or register to comment.